BOSTON SCIENTIFIC CORPORATION Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
BOSTON SCIENTIFIC CORPORATION (BSX) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax of -$2.00 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-03.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax · last filed 2017-08-03
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-06-30 was -$2.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-03-31 was -$21.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2016-12-31 was $42.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2016-09-30 was -$8.00M, a 260.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2016 was -$23.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2015 was -$39.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2014 was -$83.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2013 was -$77.00M, a 313.89% decline from fiscal 2012.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 3 month as first filed | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 6 month as first filed | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 9 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 9 month as first filed | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | -$2.00M 10-Q · filed 2017-08-03 | -$23.00M 10-Q · filed 2017-08-03 | $19.00M derived: sum of 3 quarters · filed 2017-08-03 | $11.00M derived: sum of 4 quarters · filed 2017-08-03 | ||||
| 2017-03-31 | -$21.00M 10-Q · filed 2017-05-03 | $21.00M derived: sum of 2 quarters · filed 2017-05-03 | $13.00M derived: sum of 3 quarters · filed 2017-05-03 | -$23.00M derived: sum of 4 quarters · filed 2017-08-03 | ||||
| 2016-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $34.00M derived: sum of 2 quarters · filed 2017-02-23 | -$2.00M derived: sum of 3 quarters · filed 2017-08-03 | -$23.00M 10-K · filed 2017-02-23 | ||||
| 2016-09-30 | -$8.00M 10-Q · filed 2016-11-03 | -$44.00M derived: sum of 2 quarters · filed 2017-08-03 | -$65.00M 10-Q · filed 2016-11-03 | -$137.00M derived: sum of 4 quarters · filed 2017-08-03 | ||||
| 2016-06-30 | -$36.00M 10-Q · filed 2017-08-03 | -$57.00M 10-Q · filed 2017-08-03 | -$129.00M derived: sum of 3 quarters · filed 2017-08-03 | -$124.00M derived: sum of 4 quarters · filed 2017-08-03 | ||||
| 2016-03-31 | -$21.00M 10-Q · filed 2017-05-03 | -$93.00M derived: sum of 2 quarters · filed 2017-05-03 | -$88.00M derived: sum of 3 quarters · filed 2017-05-03 | -$93.00M derived: sum of 4 quarters · filed 2017-05-03 | ||||
| 2015-12-31 | -$72.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$67.00M derived: sum of 2 quarters · filed 2017-02-23 | -$72.00M derived: sum of 3 quarters · filed 2017-02-23 | -$39.00M 10-K · filed 2017-02-23 | ||||
| 2015-09-30 | $5.00M 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $33.00M 10-Q · filed 2016-11-03 | -$91.00M derived: sum of 4 quarters · filed 2016-11-03 | ||||
| 2015-06-30 | -$5.00M 10-Q · filed 2016-08-03 | $28.00M 10-Q · filed 2016-08-03 | -$96.00M derived: sum of 3 quarters · filed 2016-08-03 | -$39.00M derived: sum of 4 quarters · filed 2016-08-03 | ||||
| 2015-03-31 | $34.00M 10-Q · filed 2016-05-04 | -$34.00M 10-Q · filed 2015-05-06 | -$91.00M derived: sum of 2 quarters · filed 2016-05-04 | -$34.00M derived: sum of 3 quarters · filed 2016-05-04 | -$41.00M derived: sum of 4 quarters · filed 2016-05-04 | |||
| 2014-12-31 | -$125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$68.00M derived: sum of 2 quarters · filed 2016-02-24 | -$75.00M derived: sum of 3 quarters · filed 2016-02-24 | -$83.00M 10-K · filed 2016-02-24 | ||||
| 2014-09-30 | $57.00M 10-Q · filed 2015-11-04 | -$57.00M 10-Q · filed 2014-11-05 | $50.00M derived: sum of 2 quarters · filed 2015-11-04 | $42.00M 10-Q · filed 2015-11-04 | -$42.00M 10-Q · filed 2014-11-05 | $33.00M derived: sum of 4 quarters · filed 2015-11-04 | ||
| 2014-06-30 | -$7.00M 10-Q · filed 2015-08-06 | $7.00M 10-Q · filed 2014-08-06 | -$13.00M 10-Q · filed 2015-08-06 | $13.00M 10-Q · filed 2014-08-06 | -$24.00M derived: sum of 3 quarters · filed 2015-08-06 | -$8.00M derived: sum of 4 quarters · filed 2015-08-06 | ||
| 2014-03-31 | $7.00M 10-Q · filed 2015-05-06 | -$17.00M derived: sum of 2 quarters · filed 2015-05-06 | -$1.00M derived: sum of 3 quarters · filed 2015-05-06 | $25.00M derived: sum of 4 quarters · filed 2015-05-06 | ||||
| 2013-12-31 | -$24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$8.00M derived: sum of 2 quarters · filed 2015-02-25 | $18.00M derived: sum of 3 quarters · filed 2015-02-25 | -$77.00M 10-K · filed 2015-02-25 | $77.00M 10-K · filed 2014-02-26 | |||
| 2013-09-30 | $16.00M 10-Q · filed 2014-11-05 | $42.00M derived: sum of 2 quarters · filed 2014-11-05 | -$53.00M 10-Q · filed 2014-11-05 | $53.00M 10-Q · filed 2013-11-05 | $120.00M derived: sum of 4 quarters · filed 2014-11-05 | |||
| 2013-06-30 | $26.00M 10-Q · filed 2014-08-06 | $71.00M 10-Q · filed 2014-08-06 | $104.00M derived: sum of 3 quarters · filed 2014-08-06 | $121.00M derived: sum of 4 quarters · filed 2014-08-06 | ||||
| 2013-03-31 | $43.00M 10-Q · filed 2014-05-08 | $45.00M 10-Q · filed 2013-05-07 | $78.00M derived: sum of 2 quarters · filed 2014-05-08 | $95.00M derived: sum of 3 quarters · filed 2014-05-08 | $102.00M derived: sum of 4 quarters · filed 2014-05-08 | |||
| 2012-12-31 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $52.00M derived: sum of 2 quarters · filed 2014-02-26 | $59.00M derived: sum of 3 quarters · filed 2014-02-26 | $36.00M 10-K · filed 2014-02-26 | $43.00M 10-K · filed 2013-02-22 | |||
| 2012-09-30 | $17.00M 10-Q · filed 2013-11-05 | $24.00M derived: sum of 2 quarters · filed 2013-11-05 | $1.00M 10-Q · filed 2013-11-05 | |||||
| 2012-06-30 | $7.00M 10-Q · filed 2013-08-07 | $26.00M 10-Q · filed 2013-08-07 | ||||||
| 2012-03-31 | $19.00M 10-Q · filed 2013-05-07 | |||||||
| 2011-12-31 | $1.00M 8-K · filed 2013-05-29 | |||||||
| 2010-12-31 | $16.00M 8-K · filed 2013-05-29 | |||||||
| 2009-12-31 | $4.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |